Causality assessment is the process of evaluating the relationship between an adverse event and a drug or medical intervention. It involves determining whether there is a reasonable possibility that the drug or intervention caused or contributed to the observed adverse event.
This assessment is a critical component of pharmacovigilance and clinical research, helping to identify potential safety issues with medications or treatments. Causality assessment typically considers factors such as temporal relationship, biological plausibility, dose-response relationship, and the presence of alternative explanations.
Causality assessment is crucial in clinical research as it helps ensure patient safety and the integrity of study results. By systematically evaluating the relationship between interventions and adverse events, researchers can identify potential risks associated with new treatments and make informed decisions about their safety profiles.
Furthermore, causality assessment plays a vital role in regulatory processes and post-marketing surveillance. It aids in the development of accurate drug labeling, supports decision-making for regulatory authorities, and contributes to the ongoing monitoring of drug safety in real-world settings.
We’re pleased to announce a strategic partnership between Axcellant and Prometheus MedTech.AI — a medtech startup developing AI-powered solutions for…
The Axcellant team has returned from the European Association of Nuclear Medicine (EANM) Annual Congress in Barcelona — and it’s…
The robust development of nuclear medicine depends on the availability of radioactive isotopes, some of which are used for diagnostic…
Copyright @ 2025 Axcellant